These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5786507)

  • 1. Resistance and susceptibility to tumours. II. An attempt to heal mice bearing the Bo4 tumour using transferred mice spleen cells.
    Dvorák R; Chlumecký J
    Neoplasma; 1969; 16(1):11-5. PubMed ID: 5786507
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
    Dvorák R; Chlumecký J
    Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance and susceptibility to tumours. I. Local reactivities of various mice to the implanted Bo4 tumour.
    Dvorák R; Rejthar A; Chlumecký J; Jasková J
    Neoplasma; 1968; 15(6):645-56. PubMed ID: 5704184
    [No Abstract]   [Full Text] [Related]  

  • 4. The adoptive transfer of concomitant immunity to murine tumor isografts with spleen cells from tumor-bearing animals.
    Deckers PJ; Edgerton BW; Thomas BS; Pilch YH
    Cancer Res; 1971 Jun; 31(6):734-42. PubMed ID: 5088484
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploratory studies of vitamin A and cyclophosphamide in tumor-bearing mice.
    Nathanson L; Maddock CL; Hall TC
    J Clin Pharmacol J New Drugs; 1969; 9(6):359-73. PubMed ID: 5260199
    [No Abstract]   [Full Text] [Related]  

  • 6. Method of solid tumour evaluation in the immunological experiment. II. A new easy complex method for evaluating resistance.
    Rejthar A; Wotke R; Wotke J
    Neoplasma; 1974; 21(1):13-9. PubMed ID: 4150904
    [No Abstract]   [Full Text] [Related]  

  • 7. On the mechanisms of tumour facilitation and tumour inhibition. Effect of the local graft-versus-host reaction.
    Medzihrský J
    Neoplasma; 1969; 16(1):3-10. PubMed ID: 5815024
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for tumours using clostridial oncolysis, antibiotics and cyclophosphamide: model trial on the UVT 15264 tumour.
    Schlechte H; Schwabe K; Mehnert WH; Schulze B; Bräuniger H
    Arch Geschwulstforsch; 1982; 52(1):41-8. PubMed ID: 7082130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of the specific transplantation tumour antigen in carcinoma BO-IV in vivo.
    Rejthar A; Wotke J
    Neoplasma; 1971; 18(1):27-31. PubMed ID: 5575433
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
    Mattern J; Jaeger S; Wayss K; Volm M
    Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antitumor immunity in animals treated with carminomycin].
    Shapovalova SP; Aleksander SK; Liashenko VA
    Antibiotiki; 1981 Apr; 26(4):302-6. PubMed ID: 7235671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational stress reduces the effectiveness of antitumor drugs in mice.
    Giraldi T; Perissin L; Zorzet S; Rapozzi V
    Ann N Y Acad Sci; 1994 Nov; 741():234-43. PubMed ID: 7825811
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 18. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of immune responses on tumor growth.
    Ichihashi H
    Gan; 1965 Jun; 56(3):223-37. PubMed ID: 5831705
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition and enhancement of the Landschütz ascites tumour with lymphoid cells.
    el-Hassan AM; Stuart AE
    J Pathol Bacteriol; 1966 Jan; 91(1):11-31. PubMed ID: 5941386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.